DaVita HealthCare (DVA) Stock Drops Despite Market Gains: Important Facts to Note

Company Performance - DaVita HealthCare (DVA) stock decreased by 3.26% to $132.26, underperforming the S&P 500 which gained 0.3% [1] - Over the past month, DVA shares increased by 3.51%, while the Medical sector rose by 7.07% and the S&P 500 by 2.09% [1] Financial Projections - DaVita is expected to report an EPS of $3.29, reflecting a growth of 27.03% year-over-year [2] - Revenue is forecasted to be $3.4 billion, indicating a 4.27% increase compared to the same quarter last year [2] Annual Estimates - For the fiscal year, earnings are projected at $10.93 per share and revenue at $13.46 billion, representing growths of 12.91% and 5.01% respectively from the previous year [3] - Recent analyst estimate revisions suggest a positive outlook for DaVita's business [3] Valuation Metrics - DaVita has a Forward P/E ratio of 12.51, which is lower than the industry average of 20.96 [6] - The company's PEG ratio stands at 0.98, compared to the industry average PEG ratio of 1.94 [6] Industry Context - The Medical - Outpatient and Home Healthcare industry is ranked 152 by Zacks, placing it in the bottom 39% of over 250 industries [7] - The Zacks Industry Rank indicates that top-rated industries outperform the lower-rated ones by a factor of 2 to 1 [7]